Search results
Results from the WOW.Com Content Network
Loperamide, sold under the brand name Imodium, among others, [1] is a medication of the opioid receptor agonist class used to decrease the frequency of diarrhea. [5] [4] It is often used for this purpose in irritable bowel syndrome, inflammatory bowel disease, short bowel syndrome, [4] Crohn's disease, and ulcerative colitis. [5]
[2] [3] It is a fixed-dose combination of the medications diphenoxylate, as the hydrochloride, an antidiarrheal; and atropine, as the sulfate, an anticholinergic. [1] It is taken by mouth. [2] Onset is typically within an hour. [4] Side effects may include abdominal pain, angioedema, glaucoma, heart problems, feeling tired, dry mouth, and ...
By binding to μ-opioid receptors, loperamide inhibits acetylcholine release and decreases excitation of neurons in the myenteric plexus, which leads to a decrease in peristalsis. [4] Decreasing intestinal motility prolongs the transit time of food content through the digestive tract, which allows for more fluid absorption; thereby alleviating ...
For example, most opioids cause sedation when given at a sufficiently high dose, but peripherally selective opioids can act on the rest of the body without entering the brain and are less likely to cause sedation. [1] These peripherally selective opioids can be used as antidiarrheals, for instance loperamide (Imodium). [2]
Diphenoxylate is used to treat diarrhea in adults; it is only available as a combination drug with a subtherapeutic dose of atropine to prevent abuse. [2] It should not be used in children due to the risk of respiratory depression. [2] It does not appear harmful to a fetus but the risks have not been fully explored. [2]
Some patients request to be switched to a different narcotic due to stigma associated with a particular drug (e.g. a patient refusing methadone due to its association with opioid addiction treatment). [4] Equianalgesic charts are also used when calculating an equivalent dosage of the same drug, but with a different route of administration.
[13] [14] Occupancy was 35% for a 0.5 mg dose and 94% for a 10 mg dose. [ 15 ] [ 14 ] At 24 hours post-dose, receptor occupancy was 19% for 0.5 mg and 82% for 25 mg. [ 15 ] [ 14 ] No serious side effects were observed, and all side effects seen were mild to moderate and were not thought to be due to aticaprant.
Management of depression is the treatment of depression that may involve a number of different therapies: medications, behavior therapy, psychotherapy, and medical devices. Depression is a symptom of some physical diseases; a side effect of some drugs and medical treatments; and a symptom of some mood disorders such as major depressive disorder ...